Compare Hasbro, Inc. (HAS) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hasbro, Inc. vs GeneDx Holdings Corp — how do they compare? Hasbro, Inc. trades at $97.48 (market cap $13.69B), while GeneDx Holdings Corp trades at $81.66 (market cap $2.44B). The key difference: Hasbro, Inc. is far larger — about 5.6× GeneDx Holdings Corp's market cap, and Hasbro, Inc. pays a 2.89% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| HAS | WGS | |
|---|---|---|
Market Cap | $13.69B | $2.44B |
Sector | Consumer Cyclical | Technology |
52-Week High | $105.88 | $167.51 |
52-Week Low | $70.95 | $34.51 |
Enterprise Value | $15.88B | $2.48B |
Dividend Yield | 2.89% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Hasbro, Inc.
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. Ownership stakes in Discovery Family, which offers programming around Hasbro brands, and owned production capabilities from Entertainment One help bolster Hasbro's multichannel presence. The firm acquired Entertainment One in 2019, bolting on popular properties like Peppa Pig and PJ Masks, and has plans to tie up with Dungeons & Dragons Beyond in 2022, offering the firm access 10 million digital tabletop players.
Read more on HAS →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
